Europe's drug regulator said on Friday that it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson's Covid-19 vaccine.

The European Medicines Agency's safety committee has also been looking at how AstraZeneca's Covid-19 vaccine is associated with very rare cases of unusual blood clots and said it was now reviewing reports of capillary leak syndrome in people given AstraZeneca's vaccine.